Phathom Pharmaceuticals
PHAT
#6720
Rank
HK$3.95 B
Marketcap
HK$57.88
Share price
-4.73%
Change (1 day)
-17.74%
Change (1 year)

Revenue for Phathom Pharmaceuticals (PHAT)

Revenue in 2024 (TTM): HK$0.20 Billion

According to Phathom Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is HK$0.20 Billion. In 2023 the company made a revenue of HK$5.32 Million an increase over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Phathom Pharmaceuticals from 2019 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) HK$0.20 B3741.08%
2023 HK$5.32 M
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA